Clinical Trials
4
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Safety and Feasibility of ActivSight(tm) in the Identification of The Ureter Via Riboflavin Fluorescence
- Conditions
- Surgical Procedure, Unspecified
- First Posted Date
- 2024-08-02
- Last Posted Date
- 2024-08-02
- Lead Sponsor
- Activ Surgical
- Registration Number
- NCT06535555
- Locations
- 🇺🇸
Center for Special Surgery, Roswell, Georgia, United States
Feasibility and Utility of Artificial Intelligence (AI) / Machine Learning (ML) - Driven Advanced Intraoperative Visualization and Identification of Critical Anatomic Structures and Procedural Phases in Laparoscopic Cholecystectomy
- Conditions
- Biliary DyskinesiaCholecystitisCholelithiasis
- First Posted Date
- 2023-03-20
- Last Posted Date
- 2024-02-21
- Lead Sponsor
- Activ Surgical
- Target Recruit Count
- 120
- Registration Number
- NCT05775133
- Locations
- 🇺🇸
Memorial Hermann Texas Medical Center, Houston, Texas, United States
Utility and Usability of ActivSight™ Laser Speckle Imaging in Visualization of Tissue Perfusion and Blood Flow During Esophageal Surgery in Humans
- Conditions
- Esophageal NeoplasmsEsophagus TumorEsophageal CancerEsophagus AdenocarcinomaEsophagus CancerEsophagus SCCEsophagus NeoplasmEsophageal DiseasesEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma
- First Posted Date
- 2022-10-24
- Last Posted Date
- 2024-02-21
- Lead Sponsor
- Activ Surgical
- Target Recruit Count
- 70
- Registration Number
- NCT05591053
- Locations
- 🇺🇸
University of Pittsburgh Medical Center - Dept of Cardiothoracic Surgery, Pittsburgh, Pennsylvania, United States
🇺🇸West Penn Hospital / Allegheny Health Network, Pittsburgh, Pennsylvania, United States
Safety and Feasibility of ActivSightTM in Human
- Conditions
- Acute CholecystitisColorectal CancerDiverticulitis, ColonicObesity, MorbidInflammatory Bowel Diseases
- First Posted Date
- 2020-11-18
- Last Posted Date
- 2024-02-21
- Lead Sponsor
- Activ Surgical
- Target Recruit Count
- 67
- Registration Number
- NCT04633512
- Locations
- 🇺🇸
Kaleida Health, University of Buffalo, Buffalo, New York, United States
🇺🇸Memorial Hermann Texas Medical Center, Houston, Texas, United States
🇺🇸Memorial Hermann Sugar Land Hospital, Sugar Land, Texas, United States